YSB Inc. (HKG:9885)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.11
0.00 (0.00%)
Apr 29, 2026, 4:08 PM HKT
-19.53%
Market Cap 3.49B
Revenue (ttm) 23.34B
Net Income (ttm) 170.22M
Shares Out 682.25M
EPS (ttm) 0.24
PE Ratio 20.87
Forward PE n/a
Dividend 0.13 (2.47%)
Ex-Dividend Date May 26, 2026
Volume 670,000
Average Volume 2,830,693
Open 5.24
Previous Close 5.11
Day's Range 5.10 - 5.26
52-Week Range 3.56 - 12.66
Beta 0.63
RSI 47.39
Earnings Date Mar 23, 2026

About YSB Inc.

YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. The company offers ClouMinihouse, a primary smart healthcare system that include Future Lou, a series of advanced point-of-care testing and monitoring devices; Cloud consultation SaaS, a digital clinic management system; and ClouWiseDoctor, a smart AI doctors-aid system. It also provides SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qu... [Read more]

Sector Healthcare
Founded 2015
Employees 6,950
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 9885
Full Company Profile

Financial Performance

In 2025, YSB Inc.'s revenue was 20.97 billion, an increase of 17.13% compared to the previous year's 17.90 billion. Earnings were 152.97 million, an increase of 409.66%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.